ARCHIVES

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

This article is from The Cancer Letter archive.

Vol. 18 No. 12 | March 20, 1992

Download PDF Visit The Full Archive

Related Articles

FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere

October 8, 1982

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

ACS Executive Proposes Efficiency Plan, Critics Fear Erosion Of Local Influence

May 1, 1998

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977